Skip to content

Author

M. Oroujeni

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma

These findings highlight how rational design can optimize in vivo pharmacokinetics while preserving binding properties essential for effective pretargeting, providing a foundation for developing novel targeted cytotoxic delivery systems with potentially improved therapeutic indexes.

Jacob Clinton, K. Westerlund, Astrid Haraldsson et al. · 0 citations
#protein folding Sep 2026

Targeted RPT of CEACAM5-Expressing Human Xenografts Using an Albumin-Binding Domain-Fused C9 Affibody: Proof-of-Principle Study.

ABD035-C9-C9-DOTA is a promising candidate for the development of targeted RPT of CEACAM5-expressing tumors and a significant increase in the survival of tumor-bearing mice and mild, transient toxicity is demonstrated.

Ruo-Nan Li, E. Papalanis, M. Oroujeni et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.